Rank | Gene Set | Z-score |
---|---|---|
1 | homocysteine metabolic process (GO:0050667) | 8.86823221 |
2 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 8.82452437 |
3 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 8.82452437 |
4 | folic acid-containing compound biosynthetic process (GO:0009396) | 8.08366284 |
5 | purine nucleotide salvage (GO:0032261) | 8.03934606 |
6 | sulfur amino acid catabolic process (GO:0000098) | 7.87571152 |
7 | adenosine metabolic process (GO:0046085) | 7.25499799 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.86059831 |
9 | cysteine metabolic process (GO:0006534) | 6.64754299 |
10 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.74386093 |
11 | pteridine-containing compound biosynthetic process (GO:0042559) | 5.61680575 |
12 | white fat cell differentiation (GO:0050872) | 5.55058354 |
13 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.50334729 |
14 | negative regulation of DNA biosynthetic process (GO:2000279) | 5.43159924 |
15 | microtubule nucleation (GO:0007020) | 5.38398892 |
16 | mitochondrial RNA metabolic process (GO:0000959) | 5.13876301 |
17 | L-serine metabolic process (GO:0006563) | 5.07534150 |
18 | ribosomal small subunit assembly (GO:0000028) | 4.82660174 |
19 | galactose catabolic process (GO:0019388) | 4.77728629 |
20 | regulation of vitamin metabolic process (GO:0030656) | 4.65211487 |
21 | IMP biosynthetic process (GO:0006188) | 4.60897807 |
22 | purine-containing compound salvage (GO:0043101) | 4.59158546 |
23 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.57575961 |
24 | inner ear receptor cell development (GO:0060119) | 4.56653872 |
25 | protein-cofactor linkage (GO:0018065) | 4.49945689 |
26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47617127 |
27 | nucleotide salvage (GO:0043173) | 4.43945164 |
28 | desmosome organization (GO:0002934) | 4.41619521 |
29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.39340168 |
30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.39340168 |
31 | negative regulation of Ras GTPase activity (GO:0034261) | 4.33367609 |
32 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.33329425 |
33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32359304 |
34 | neutrophil activation involved in immune response (GO:0002283) | 4.25830574 |
35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.25033929 |
36 | NADH dehydrogenase complex assembly (GO:0010257) | 4.25033929 |
37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.25033929 |
38 | serine family amino acid biosynthetic process (GO:0009070) | 4.22506788 |
39 | galactose metabolic process (GO:0006012) | 4.15220415 |
40 | regulation of gonadotropin secretion (GO:0032276) | 4.14792432 |
41 | tetrahydrofolate metabolic process (GO:0046653) | 4.10280213 |
42 | protein-chromophore linkage (GO:0018298) | 4.09230665 |
43 | cartilage morphogenesis (GO:0060536) | 4.06110453 |
44 | rRNA methylation (GO:0031167) | 4.02144466 |
45 | folic acid-containing compound metabolic process (GO:0006760) | 4.02088305 |
46 | cell migration involved in heart development (GO:0060973) | 3.99092522 |
47 | IMP metabolic process (GO:0046040) | 3.94485517 |
48 | regulation of sequestering of triglyceride (GO:0010889) | 3.90818017 |
49 | rRNA modification (GO:0000154) | 3.89899807 |
50 | CENP-A containing nucleosome assembly (GO:0034080) | 3.86520751 |
51 | pseudouridine synthesis (GO:0001522) | 3.83074580 |
52 | regulation of tight junction assembly (GO:2000810) | 3.80806195 |
53 | response to interferon-beta (GO:0035456) | 3.80121166 |
54 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.79970340 |
55 | negative regulation of telomerase activity (GO:0051974) | 3.76359273 |
56 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.74961225 |
57 | polyamine biosynthetic process (GO:0006596) | 3.72494304 |
58 | protein complex biogenesis (GO:0070271) | 3.65153480 |
59 | myeloid dendritic cell activation (GO:0001773) | 3.62864846 |
60 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.62345934 |
61 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.61804976 |
62 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.61800363 |
63 | tRNA modification (GO:0006400) | 3.58888494 |
64 | chromatin remodeling at centromere (GO:0031055) | 3.57643274 |
65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.55130234 |
66 | response to type I interferon (GO:0034340) | 3.55082436 |
67 | sulfur amino acid biosynthetic process (GO:0000097) | 3.53870275 |
68 | type I interferon signaling pathway (GO:0060337) | 3.53784945 |
69 | cellular response to type I interferon (GO:0071357) | 3.53784945 |
70 | cochlea development (GO:0090102) | 3.52327543 |
71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51433859 |
72 | mast cell activation (GO:0045576) | 3.47161653 |
73 | polyamine metabolic process (GO:0006595) | 3.46873035 |
74 | defense response to protozoan (GO:0042832) | 3.46054119 |
75 | folic acid transport (GO:0015884) | 3.45116189 |
76 | histone H4-K12 acetylation (GO:0043983) | 3.43260423 |
77 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.41012594 |
78 | positive regulation of B cell differentiation (GO:0045579) | 3.40614642 |
79 | cellular response to interferon-beta (GO:0035458) | 3.39357061 |
80 | glycoside metabolic process (GO:0016137) | 3.38820755 |
81 | granulocyte activation (GO:0036230) | 3.36724355 |
82 | negative regulation of catenin import into nucleus (GO:0035414) | 3.35659088 |
83 | myeloid dendritic cell differentiation (GO:0043011) | 3.34822996 |
84 | inner mitochondrial membrane organization (GO:0007007) | 3.34778888 |
85 | viral transcription (GO:0019083) | 3.34568814 |
86 | pteridine-containing compound metabolic process (GO:0042558) | 3.33734176 |
87 | tRNA processing (GO:0008033) | 3.32316422 |
88 | positive regulation of interferon-alpha production (GO:0032727) | 3.30107826 |
89 | immunoglobulin mediated immune response (GO:0016064) | 3.29108262 |
90 | neutrophil activation (GO:0042119) | 3.28105197 |
91 | response to interferon-alpha (GO:0035455) | 3.27030363 |
92 | serine family amino acid catabolic process (GO:0009071) | 3.27016705 |
93 | respiratory burst (GO:0045730) | 3.25654278 |
94 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.25366104 |
95 | response to protozoan (GO:0001562) | 3.25087492 |
96 | response to peptidoglycan (GO:0032494) | 3.25050994 |
97 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.23784745 |
98 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.23362891 |
99 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.23362891 |
100 | T cell migration (GO:0072678) | 3.20683773 |
101 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.20428572 |
102 | sulfur amino acid metabolic process (GO:0000096) | 3.19699389 |
103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19678304 |
104 | organic cation transport (GO:0015695) | 3.19420487 |
105 | primary amino compound metabolic process (GO:1901160) | 3.19217079 |
106 | nucleoside transmembrane transport (GO:1901642) | 3.17488922 |
107 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16765602 |
108 | definitive hemopoiesis (GO:0060216) | 3.16078672 |
109 | regulation of endothelial cell differentiation (GO:0045601) | 3.15161272 |
110 | regulation of interferon-alpha production (GO:0032647) | 3.13249747 |
111 | leukocyte aggregation (GO:0070486) | 3.11790466 |
112 | cellular response to zinc ion (GO:0071294) | 3.11770055 |
113 | translational termination (GO:0006415) | 3.10839051 |
114 | regulation of B cell differentiation (GO:0045577) | 3.09228476 |
115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.08452489 |
116 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.07890290 |
117 | GMP metabolic process (GO:0046037) | 3.06133741 |
118 | DNA ligation (GO:0006266) | 3.05503892 |
119 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.04583810 |
120 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04050272 |
121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03833576 |
122 | ribosome biogenesis (GO:0042254) | 3.02105938 |
123 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01949980 |
124 | ribosomal small subunit biogenesis (GO:0042274) | 3.01004914 |
125 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00770309 |
126 | negative regulation of viral genome replication (GO:0045071) | 2.99611404 |
127 | NIK/NF-kappaB signaling (GO:0038061) | 2.99157861 |
128 | behavioral fear response (GO:0001662) | 2.98995719 |
129 | behavioral defense response (GO:0002209) | 2.98995719 |
130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96067453 |
131 | negative regulation of acute inflammatory response (GO:0002674) | 2.93729848 |
132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93678175 |
133 | myeloid cell activation involved in immune response (GO:0002275) | 2.93520284 |
134 | one-carbon metabolic process (GO:0006730) | 2.93484936 |
135 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92741169 |
136 | acrosome assembly (GO:0001675) | 2.90821868 |
137 | regulation of cholesterol storage (GO:0010885) | 2.90648723 |
138 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.90534108 |
139 | response to lipoprotein particle (GO:0055094) | 2.90052164 |
140 | positive regulation of macrophage differentiation (GO:0045651) | 2.88336249 |
141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87709499 |
142 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.87502192 |
143 | GTP biosynthetic process (GO:0006183) | 2.87259089 |
144 | interferon-gamma production (GO:0032609) | 2.86198352 |
145 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85798205 |
146 | negative thymic T cell selection (GO:0045060) | 2.84106570 |
147 | cotranslational protein targeting to membrane (GO:0006613) | 2.83073214 |
148 | B cell mediated immunity (GO:0019724) | 2.83013202 |
149 | proteasome assembly (GO:0043248) | 2.82361252 |
150 | protein targeting to ER (GO:0045047) | 2.81445657 |
151 | leukocyte degranulation (GO:0043299) | 2.80749632 |
152 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.80523263 |
153 | regulation of telomerase activity (GO:0051972) | 2.80159501 |
154 | B cell receptor signaling pathway (GO:0050853) | 2.79746217 |
155 | negative T cell selection (GO:0043383) | 2.77884063 |
156 | dendritic cell differentiation (GO:0097028) | 2.77688059 |
157 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.76883612 |
158 | platelet dense granule organization (GO:0060155) | 2.76826197 |
159 | response to muramyl dipeptide (GO:0032495) | 2.76670730 |
160 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.76195120 |
161 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75750230 |
162 | innervation (GO:0060384) | 2.75489728 |
163 | mature B cell differentiation (GO:0002335) | 2.75083207 |
164 | DNA replication-independent nucleosome organization (GO:0034724) | 2.75047512 |
165 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.75047512 |
166 | regulation of RIG-I signaling pathway (GO:0039535) | 2.74817140 |
167 | histone exchange (GO:0043486) | 2.73776715 |
168 | GPI anchor biosynthetic process (GO:0006506) | 2.73590103 |
169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.72280409 |
170 | lymph node development (GO:0048535) | 2.70839423 |
171 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.69878336 |
172 | T cell homeostasis (GO:0043029) | 2.69697952 |
173 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69242368 |
174 | myeloid leukocyte activation (GO:0002274) | 2.68093612 |
175 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67033882 |
176 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66837775 |
177 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.65026881 |
178 | positive regulation of interleukin-2 production (GO:0032743) | 2.64971675 |
179 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.64842033 |
180 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.62739360 |
181 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62200432 |
182 | regulation of necroptotic process (GO:0060544) | 2.61153908 |
183 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.61055500 |
184 | regulation of antigen processing and presentation (GO:0002577) | 2.60527884 |
185 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.59285684 |
186 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.59107619 |
187 | natural killer cell activation (GO:0030101) | 2.58601467 |
188 | monocyte chemotaxis (GO:0002548) | 2.57262269 |
189 | viral life cycle (GO:0019058) | 2.56922983 |
190 | regulation of T-helper 1 type immune response (GO:0002825) | 2.56753737 |
191 | translational elongation (GO:0006414) | 2.56667682 |
192 | T-helper 1 type immune response (GO:0042088) | 2.55050372 |
193 | positive regulation of interleukin-12 production (GO:0032735) | 2.54640778 |
194 | positive regulation of isotype switching (GO:0045830) | 2.53436005 |
195 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53253863 |
196 | modulation by symbiont of host immune response (GO:0052553) | 2.53253863 |
197 | modulation by symbiont of host defense response (GO:0052031) | 2.53253863 |
198 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53253863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.75420648 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.97025955 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.54417075 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53671355 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.42692580 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.71270597 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49518918 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.29497422 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29314115 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.18366002 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.13679745 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87489018 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.87215644 |
14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.86191539 |
15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.80594117 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.70476051 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70044983 |
18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67218524 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.66833394 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64358630 |
21 | VDR_22108803_ChIP-Seq_LS180_Human | 2.59105960 |
22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58473294 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.57853989 |
24 | MYB_26560356_Chip-Seq_TH2_Human | 2.20984040 |
25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.19606841 |
26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.17996641 |
27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11171329 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.10019671 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04242893 |
30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02635458 |
31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 12.0660454 |
32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98861192 |
33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97510672 |
34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.94263826 |
35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.94054473 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93046941 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91516815 |
38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83852179 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82911051 |
40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.77346845 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77337264 |
42 | MAF_26560356_Chip-Seq_TH1_Human | 1.77095743 |
43 | MYB_26560356_Chip-Seq_TH1_Human | 1.76654392 |
44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74978286 |
45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73580486 |
46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72999141 |
47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72056368 |
48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70370923 |
49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.70311694 |
50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63831148 |
51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62650621 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.62419813 |
53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58348971 |
54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58133993 |
55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53711352 |
56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51192375 |
57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50865143 |
58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50179867 |
59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49909081 |
60 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.49303893 |
61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.49231480 |
62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48384249 |
63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.48377128 |
64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45061691 |
65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44812223 |
66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44139217 |
67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40793490 |
68 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40180052 |
69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.40118221 |
70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36245045 |
71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35302277 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34499013 |
73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33604541 |
74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33321825 |
75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.31714787 |
76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30335070 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.30328798 |
78 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29732638 |
79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29608724 |
80 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.29551413 |
81 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29529909 |
82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.26598376 |
83 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.23816589 |
84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23733369 |
85 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21875706 |
86 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21289773 |
87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19546075 |
88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19470192 |
89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18909707 |
90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17965795 |
91 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17323398 |
92 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16159153 |
93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15752268 |
94 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15312645 |
95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13654584 |
96 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.12009334 |
97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11680854 |
98 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11534733 |
99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11391548 |
100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11085419 |
101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10309285 |
102 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09203771 |
103 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08928445 |
104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08691274 |
105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07926815 |
106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07874217 |
107 | MAF_26560356_Chip-Seq_TH2_Human | 1.06173415 |
108 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03683791 |
109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03426168 |
110 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99705888 |
111 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.99699675 |
112 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.99404563 |
113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97688029 |
114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97192714 |
115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96700737 |
116 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96651312 |
117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95544225 |
118 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95464322 |
119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94710221 |
120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94615220 |
121 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94526641 |
122 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94495016 |
123 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93529875 |
124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93181316 |
125 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92961899 |
126 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92549504 |
127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.92454498 |
128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.92149237 |
129 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.92135109 |
130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91742011 |
131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90652251 |
132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90579412 |
133 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89514543 |
134 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89205576 |
135 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89205576 |
136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.87443739 |
137 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.86642647 |
138 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86242694 |
139 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86232074 |
140 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84830012 |
141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83937236 |
142 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83847326 |
143 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83655374 |
144 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83587528 |
145 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83069390 |
146 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.82552488 |
147 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82401449 |
148 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82331623 |
149 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81944040 |
150 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81944040 |
151 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.81938846 |
152 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.81788954 |
153 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81422832 |
154 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.80539966 |
155 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80192261 |
156 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.78232858 |
157 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78027415 |
158 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76759824 |
159 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76644176 |
160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.75924427 |
161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75391400 |
162 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.75334931 |
163 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.74761999 |
164 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74664940 |
165 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.74579627 |
166 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.73983991 |
167 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.73071957 |
168 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.72654557 |
169 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.71682726 |
170 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.70000009 |
171 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.69606732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.83195009 |
2 | MP0001835_abnormal_antigen_presentation | 4.67375091 |
3 | MP0005670_abnormal_white_adipose | 4.51236779 |
4 | MP0005646_abnormal_pituitary_gland | 4.33577833 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.87596118 |
6 | MP0005671_abnormal_response_to | 3.77489645 |
7 | MP0008995_early_reproductive_senescence | 3.60154123 |
8 | MP0009785_altered_susceptibility_to | 3.51821470 |
9 | MP0002148_abnormal_hypersensitivity_rea | 3.45958144 |
10 | MP0000685_abnormal_immune_system | 3.42758182 |
11 | MP0000013_abnormal_adipose_tissue | 3.33365371 |
12 | MP0003436_decreased_susceptibility_to | 3.12524304 |
13 | MP0005000_abnormal_immune_tolerance | 3.09945772 |
14 | MP0003724_increased_susceptibility_to | 3.08043303 |
15 | MP0002938_white_spotting | 3.05176741 |
16 | MP0002736_abnormal_nociception_after | 2.94590834 |
17 | MP0005025_abnormal_response_to | 2.89380759 |
18 | MP0001800_abnormal_humoral_immune | 2.87399861 |
19 | MP0002452_abnormal_antigen_presenting | 2.78001863 |
20 | MP0001790_abnormal_immune_system | 2.74137212 |
21 | MP0005387_immune_system_phenotype | 2.74137212 |
22 | MP0004885_abnormal_endolymph | 2.70980320 |
23 | MP0002723_abnormal_immune_serum | 2.70320188 |
24 | MP0002419_abnormal_innate_immunity | 2.68055537 |
25 | MP0003763_abnormal_thymus_physiology | 2.66004015 |
26 | MP0002420_abnormal_adaptive_immunity | 2.61560581 |
27 | MP0001819_abnormal_immune_cell | 2.60881755 |
28 | MP0003705_abnormal_hypodermis_morpholog | 2.51035830 |
29 | MP0002166_altered_tumor_susceptibility | 2.48424082 |
30 | MP0001661_extended_life_span | 2.41060284 |
31 | MP0006082_CNS_inflammation | 2.35386830 |
32 | MP0005464_abnormal_platelet_physiology | 2.35361857 |
33 | MP0001764_abnormal_homeostasis | 2.31336046 |
34 | MP0005367_renal/urinary_system_phenotyp | 2.28698624 |
35 | MP0000516_abnormal_urinary_system | 2.28698624 |
36 | MP0002006_tumorigenesis | 2.28055870 |
37 | MP0002398_abnormal_bone_marrow | 2.25725754 |
38 | MP0000716_abnormal_immune_system | 2.09184596 |
39 | MP0001853_heart_inflammation | 2.06360060 |
40 | MP0010155_abnormal_intestine_physiology | 2.05963909 |
41 | MP0002396_abnormal_hematopoietic_system | 2.05862650 |
42 | MP0009333_abnormal_splenocyte_physiolog | 2.01427290 |
43 | MP0002405_respiratory_system_inflammati | 2.00230364 |
44 | MP0005332_abnormal_amino_acid | 1.98742948 |
45 | MP0004185_abnormal_adipocyte_glucose | 1.97678443 |
46 | MP0005174_abnormal_tail_pigmentation | 1.86980460 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.81552612 |
48 | MP0000689_abnormal_spleen_morphology | 1.81492324 |
49 | MP0002722_abnormal_immune_system | 1.79181933 |
50 | MP0001845_abnormal_inflammatory_respons | 1.78940500 |
51 | MP0008872_abnormal_physiological_respon | 1.78316296 |
52 | MP0002429_abnormal_blood_cell | 1.77801405 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.76515162 |
54 | MP0001545_abnormal_hematopoietic_system | 1.76515162 |
55 | MP0004808_abnormal_hematopoietic_stem | 1.76353843 |
56 | MP0004947_skin_inflammation | 1.68468843 |
57 | MP0004043_abnormal_pH_regulation | 1.63665443 |
58 | MP0001533_abnormal_skeleton_physiology | 1.58590278 |
59 | MP0002837_dystrophic_cardiac_calcinosis | 1.57222847 |
60 | MP0001873_stomach_inflammation | 1.56144382 |
61 | MP0001968_abnormal_touch/_nociception | 1.55268344 |
62 | MP0000490_abnormal_crypts_of | 1.54170886 |
63 | MP0003866_abnormal_defecation | 1.52901982 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.47645072 |
65 | MP0008469_abnormal_protein_level | 1.45432038 |
66 | MP0005085_abnormal_gallbladder_physiolo | 1.43941318 |
67 | MP0003786_premature_aging | 1.42984089 |
68 | MP0004510_myositis | 1.40912286 |
69 | MP0005551_abnormal_eye_electrophysiolog | 1.39703057 |
70 | MP0005310_abnormal_salivary_gland | 1.39015172 |
71 | MP0005058_abnormal_lysosome_morphology | 1.38621134 |
72 | MP0000703_abnormal_thymus_morphology | 1.34013930 |
73 | MP0000858_altered_metastatic_potential | 1.31586190 |
74 | MP0006054_spinal_hemorrhage | 1.31099520 |
75 | MP0000647_abnormal_sebaceous_gland | 1.30858667 |
76 | MP0009764_decreased_sensitivity_to | 1.30699435 |
77 | MP0002735_abnormal_chemical_nociception | 1.29649085 |
78 | MP0002009_preneoplasia | 1.23818789 |
79 | MP0003303_peritoneal_inflammation | 1.22853900 |
80 | MP0005253_abnormal_eye_physiology | 1.22340298 |
81 | MP0002933_joint_inflammation | 1.21877649 |
82 | MP0005075_abnormal_melanosome_morpholog | 1.20327505 |
83 | MP0000343_altered_response_to | 1.17980474 |
84 | MP0000026_abnormal_inner_ear | 1.16552098 |
85 | MP0003448_altered_tumor_morphology | 1.10671263 |
86 | MP0002160_abnormal_reproductive_system | 1.09048941 |
87 | MP0009379_abnormal_foot_pigmentation | 1.05816786 |
88 | MP0002998_abnormal_bone_remodeling | 1.05270551 |
89 | MP0003300_gastrointestinal_ulcer | 1.05019750 |
90 | MP0004019_abnormal_vitamin_homeostasis | 1.04732822 |
91 | MP0009643_abnormal_urine_homeostasis | 1.04583481 |
92 | MP0002095_abnormal_skin_pigmentation | 1.04377658 |
93 | MP0001756_abnormal_urination | 1.03845777 |
94 | MP0003252_abnormal_bile_duct | 1.03162755 |
95 | MP0009697_abnormal_copulation | 0.99879629 |
96 | MP0005636_abnormal_mineral_homeostasis | 0.99577704 |
97 | MP0002132_abnormal_respiratory_system | 0.99274129 |
98 | MP0000015_abnormal_ear_pigmentation | 0.99099720 |
99 | MP0006072_abnormal_retinal_apoptosis | 0.98637192 |
100 | MP0001986_abnormal_taste_sensitivity | 0.97544284 |
101 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97141734 |
102 | MP0000534_abnormal_ureter_morphology | 0.95938380 |
103 | MP0003828_pulmonary_edema | 0.93822644 |
104 | MP0002876_abnormal_thyroid_physiology | 0.93647443 |
105 | MP0003186_abnormal_redox_activity | 0.93407374 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.93176669 |
107 | MP0009278_abnormal_bone_marrow | 0.93159791 |
108 | MP0000003_abnormal_adipose_tissue | 0.91829718 |
109 | MP0004147_increased_porphyrin_level | 0.91234679 |
110 | MP0008058_abnormal_DNA_repair | 0.88046526 |
111 | MP0008789_abnormal_olfactory_epithelium | 0.86509781 |
112 | MP0001851_eye_inflammation | 0.86183590 |
113 | MP0005319_abnormal_enzyme/_coenzyme | 0.85804133 |
114 | MP0004133_heterotaxia | 0.84680444 |
115 | MP0005376_homeostasis/metabolism_phenot | 0.83881934 |
116 | MP0002138_abnormal_hepatobiliary_system | 0.83510552 |
117 | MP0000631_abnormal_neuroendocrine_gland | 0.82895524 |
118 | MP0003172_abnormal_lysosome_physiology | 0.82704218 |
119 | MP0001963_abnormal_hearing_physiology | 0.82019035 |
120 | MP0001348_abnormal_lacrimal_gland | 0.81873036 |
121 | MP0003646_muscle_fatigue | 0.79940299 |
122 | MP0005164_abnormal_response_to | 0.79807165 |
123 | MP0005365_abnormal_bile_salt | 0.78675638 |
124 | MP0005390_skeleton_phenotype | 0.78193629 |
125 | MP0002069_abnormal_eating/drinking_beha | 0.78067292 |
126 | MP0000372_irregular_coat_pigmentation | 0.77453227 |
127 | MP0003943_abnormal_hepatobiliary_system | 0.76562551 |
128 | MP0002234_abnormal_pharynx_morphology | 0.76017713 |
129 | MP0002019_abnormal_tumor_incidence | 0.73912240 |
130 | MP0006292_abnormal_olfactory_placode | 0.73832501 |
131 | MP0004782_abnormal_surfactant_physiolog | 0.72887521 |
132 | MP0009763_increased_sensitivity_to | 0.72793094 |
133 | MP0006036_abnormal_mitochondrial_physio | 0.71902190 |
134 | MP0001944_abnormal_pancreas_morphology | 0.71508651 |
135 | MP0003191_abnormal_cellular_cholesterol | 0.71095492 |
136 | MP0004145_abnormal_muscle_electrophysio | 0.70096773 |
137 | MP0003183_abnormal_peptide_metabolism | 0.69449502 |
138 | MP0009765_abnormal_xenobiotic_induced | 0.69198318 |
139 | MP0003795_abnormal_bone_structure | 0.68970031 |
140 | MP0004130_abnormal_muscle_cell | 0.68809840 |
141 | MP0005647_abnormal_sex_gland | 0.68730568 |
142 | MP0008007_abnormal_cellular_replicative | 0.67820474 |
143 | MP0001663_abnormal_digestive_system | 0.67597811 |
144 | MP0008057_abnormal_DNA_replication | 0.67316286 |
145 | MP0005389_reproductive_system_phenotype | 0.66485485 |
146 | MP0000653_abnormal_sex_gland | 0.64827165 |
147 | MP0002163_abnormal_gland_morphology | 0.63227893 |
148 | MP0008873_increased_physiological_sensi | 0.63182787 |
149 | MP0002078_abnormal_glucose_homeostasis | 0.61759135 |
150 | MP0005166_decreased_susceptibility_to | 0.61356223 |
151 | MP0001905_abnormal_dopamine_level | 0.60740056 |
152 | MP0005334_abnormal_fat_pad | 0.60603529 |
153 | MP0002877_abnormal_melanocyte_morpholog | 0.59955292 |
154 | MP0000750_abnormal_muscle_regeneration | 0.59794214 |
155 | MP0003638_abnormal_response/metabolism_ | 0.59163596 |
156 | MP0002102_abnormal_ear_morphology | 0.58901510 |
157 | MP0003075_altered_response_to | 0.58869579 |
158 | MP0003656_abnormal_erythrocyte_physiolo | 0.58841682 |
159 | MP0001270_distended_abdomen | 0.58592176 |
160 | MP0010352_gastrointestinal_tract_polyps | 0.57280920 |
161 | MP0002136_abnormal_kidney_physiology | 0.56268674 |
162 | MP0005171_absent_coat_pigmentation | 0.56097386 |
163 | MP0000249_abnormal_blood_vessel | 0.55579865 |
164 | MP0005084_abnormal_gallbladder_morpholo | 0.55331078 |
165 | MP0002210_abnormal_sex_determination | 0.55165715 |
166 | MP0001919_abnormal_reproductive_system | 0.52636433 |
167 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52600859 |
168 | MP0003453_abnormal_keratinocyte_physiol | 0.52300472 |
169 | MP0000313_abnormal_cell_death | 0.50810476 |
170 | MP0000477_abnormal_intestine_morphology | 0.48022800 |
171 | MP0000371_diluted_coat_color | 0.47607927 |
172 | MP0001879_abnormal_lymphatic_vessel | 0.47526702 |
173 | MP0001191_abnormal_skin_condition | 0.47391354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of alanine metabolism (HP:0010916) | 8.60343439 |
2 | Hyperalaninemia (HP:0003348) | 8.60343439 |
3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 8.60343439 |
4 | Constricted visual fields (HP:0001133) | 6.14484552 |
5 | Congenital sensorineural hearing impairment (HP:0008527) | 5.41346163 |
6 | Recurrent abscess formation (HP:0002722) | 5.23114176 |
7 | Eczematoid dermatitis (HP:0000976) | 4.91946934 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.82991692 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.78314389 |
10 | White forelock (HP:0002211) | 4.57250434 |
11 | Patchy hypopigmentation of hair (HP:0011365) | 4.49489579 |
12 | Myositis (HP:0100614) | 4.31130616 |
13 | Abnormal umbilical cord blood vessels (HP:0011403) | 4.30200582 |
14 | Single umbilical artery (HP:0001195) | 4.30200582 |
15 | Abnormality of the fetal cardiovascular system (HP:0010948) | 4.30200582 |
16 | Esophageal varix (HP:0002040) | 4.29219592 |
17 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.28928294 |
18 | Petechiae (HP:0000967) | 3.99274366 |
19 | Vacuolated lymphocytes (HP:0001922) | 3.96695720 |
20 | Abnormality of serum amino acid levels (HP:0003112) | 3.93605470 |
21 | Recurrent fungal infections (HP:0002841) | 3.86181048 |
22 | Thrombocytosis (HP:0001894) | 3.82623676 |
23 | Anorexia (HP:0002039) | 3.69423411 |
24 | Generalized aminoaciduria (HP:0002909) | 3.56035695 |
25 | Abnormality of homocysteine metabolism (HP:0010919) | 3.52073042 |
26 | Homocystinuria (HP:0002156) | 3.52073042 |
27 | Abnormality of macrophages (HP:0004311) | 3.50430466 |
28 | Recurrent skin infections (HP:0001581) | 3.47276289 |
29 | IgM deficiency (HP:0002850) | 3.44497977 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.41952731 |
31 | Recurrent viral infections (HP:0004429) | 3.36813241 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34691562 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34691562 |
34 | Chronic otitis media (HP:0000389) | 3.32670346 |
35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.29524091 |
36 | Conjunctival telangiectasia (HP:0000524) | 3.28030349 |
37 | Abnormal number of erythroid precursors (HP:0012131) | 3.26637150 |
38 | Myocardial infarction (HP:0001658) | 3.26461768 |
39 | Stomatitis (HP:0010280) | 3.26236618 |
40 | Prolonged bleeding time (HP:0003010) | 3.21721273 |
41 | Retrobulbar optic neuritis (HP:0100654) | 3.20986424 |
42 | Optic neuritis (HP:0100653) | 3.20986424 |
43 | Orchitis (HP:0100796) | 3.18366200 |
44 | Autoimmune thrombocytopenia (HP:0001973) | 3.12148431 |
45 | Vasculitis (HP:0002633) | 3.08903418 |
46 | Recurrent bronchitis (HP:0002837) | 3.06272224 |
47 | Birth length less than 3rd percentile (HP:0003561) | 3.05986642 |
48 | Increased IgM level (HP:0003496) | 3.03657371 |
49 | IgG deficiency (HP:0004315) | 3.01562516 |
50 | Nausea (HP:0002018) | 2.97856668 |
51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97829054 |
52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96648272 |
53 | Obstructive lung disease (HP:0006536) | 2.95692101 |
54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95692101 |
55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.95145899 |
56 | Panhypogammaglobulinemia (HP:0003139) | 2.90313828 |
57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.88676046 |
58 | Abnormality of T cell number (HP:0011839) | 2.88037743 |
59 | Meningitis (HP:0001287) | 2.86969179 |
60 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.85341810 |
61 | Reticulocytopenia (HP:0001896) | 2.85047664 |
62 | Abnormality of the umbilical cord (HP:0010881) | 2.84731677 |
63 | Abnormality of T cells (HP:0002843) | 2.82728865 |
64 | Agammaglobulinemia (HP:0004432) | 2.81922567 |
65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.79518857 |
66 | Poor speech (HP:0002465) | 2.75868077 |
67 | Abnormality of B cell number (HP:0010975) | 2.71607051 |
68 | B lymphocytopenia (HP:0010976) | 2.71607051 |
69 | Oligomenorrhea (HP:0000876) | 2.71120972 |
70 | T lymphocytopenia (HP:0005403) | 2.70402600 |
71 | Abnormality of T cell physiology (HP:0011840) | 2.69623908 |
72 | Cellulitis (HP:0100658) | 2.68951830 |
73 | Pulmonary embolism (HP:0002204) | 2.68675066 |
74 | Gastrointestinal stroma tumor (HP:0100723) | 2.68537871 |
75 | Pustule (HP:0200039) | 2.66939458 |
76 | Purpura (HP:0000979) | 2.66392252 |
77 | Action tremor (HP:0002345) | 2.66155600 |
78 | Epistaxis (HP:0000421) | 2.64766023 |
79 | Lymphopenia (HP:0001888) | 2.64148853 |
80 | Hyperglycinemia (HP:0002154) | 2.63821978 |
81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61578489 |
82 | Maternal diabetes (HP:0009800) | 2.59165525 |
83 | Aplastic anemia (HP:0001915) | 2.58752658 |
84 | Attenuation of retinal blood vessels (HP:0007843) | 2.55396579 |
85 | Heterochromia iridis (HP:0001100) | 2.55103406 |
86 | Hypergammaglobulinemia (HP:0010702) | 2.54957798 |
87 | Leukocytosis (HP:0001974) | 2.54863618 |
88 | Chronic diarrhea (HP:0002028) | 2.54145922 |
89 | Thyroiditis (HP:0100646) | 2.53118078 |
90 | Gingival bleeding (HP:0000225) | 2.52404441 |
91 | Gingivitis (HP:0000230) | 2.52019126 |
92 | Severe combined immunodeficiency (HP:0004430) | 2.48965414 |
93 | Autoimmune hemolytic anemia (HP:0001890) | 2.48280918 |
94 | Type I transferrin isoform profile (HP:0003642) | 2.42490683 |
95 | Interstitial pulmonary disease (HP:0006530) | 2.40391506 |
96 | Pigmentary retinal degeneration (HP:0001146) | 2.38748053 |
97 | Hemoptysis (HP:0002105) | 2.38650249 |
98 | Recurrent pneumonia (HP:0006532) | 2.35603258 |
99 | Granulocytopenia (HP:0001913) | 2.35476913 |
100 | Abnormality of eosinophils (HP:0001879) | 2.34963718 |
101 | Eosinophilia (HP:0001880) | 2.34822152 |
102 | Acute necrotizing encephalopathy (HP:0006965) | 2.34393010 |
103 | Basal ganglia calcification (HP:0002135) | 2.32734183 |
104 | Reduced antithrombin III activity (HP:0001976) | 2.32221624 |
105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31970571 |
106 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.30095108 |
107 | Chorioretinal atrophy (HP:0000533) | 2.29687280 |
108 | Pallor (HP:0000980) | 2.28751818 |
109 | Inflammation of the large intestine (HP:0002037) | 2.28304053 |
110 | Spontaneous hematomas (HP:0007420) | 2.26688071 |
111 | Lactic acidosis (HP:0003128) | 2.26162075 |
112 | Methylmalonic acidemia (HP:0002912) | 2.25820621 |
113 | Mitochondrial inheritance (HP:0001427) | 2.25636187 |
114 | Acute encephalopathy (HP:0006846) | 2.25140917 |
115 | Arterial thrombosis (HP:0004420) | 2.24975325 |
116 | Periodontitis (HP:0000704) | 2.24932638 |
117 | Hypoplasia of the thymus (HP:0000778) | 2.23762996 |
118 | Increased serum lactate (HP:0002151) | 2.23657506 |
119 | Hypoalphalipoproteinemia (HP:0003233) | 2.22890275 |
120 | Fatigue (HP:0012378) | 2.21188561 |
121 | Pulmonary infiltrates (HP:0002113) | 2.20776182 |
122 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20210379 |
123 | Neutropenia (HP:0001875) | 2.20042382 |
124 | Thrombophlebitis (HP:0004418) | 2.19143368 |
125 | Hypoproteinemia (HP:0003075) | 2.19094870 |
126 | Osteomyelitis (HP:0002754) | 2.18256004 |
127 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17875170 |
128 | Increased IgE level (HP:0003212) | 2.17069886 |
129 | Gastrointestinal inflammation (HP:0004386) | 2.16675745 |
130 | Combined immunodeficiency (HP:0005387) | 2.16410458 |
131 | Encephalitis (HP:0002383) | 2.16358782 |
132 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.15817169 |
133 | Increased serum pyruvate (HP:0003542) | 2.15249005 |
134 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14536296 |
135 | Lymphoma (HP:0002665) | 2.14463693 |
136 | IgA deficiency (HP:0002720) | 2.14261902 |
137 | Hyperphosphaturia (HP:0003109) | 2.14254058 |
138 | Abnormality of the prostate (HP:0008775) | 2.11586911 |
139 | Metabolic acidosis (HP:0001942) | 2.10579980 |
140 | Keratoconjunctivitis sicca (HP:0001097) | 2.10415188 |
141 | Myopathic facies (HP:0002058) | 2.09054113 |
142 | Exertional dyspnea (HP:0002875) | 2.08782146 |
143 | Nasal polyposis (HP:0100582) | 2.05659314 |
144 | Pendular nystagmus (HP:0012043) | 2.05422309 |
145 | Visceral angiomatosis (HP:0100761) | 2.01175104 |
146 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.01076238 |
147 | Keratoconjunctivitis (HP:0001096) | 2.00615739 |
148 | Abnormality of the nasal mucosa (HP:0000433) | 2.00576310 |
149 | Urticaria (HP:0001025) | 2.00353780 |
150 | Cortical visual impairment (HP:0100704) | 1.99254693 |
151 | Hepatocellular necrosis (HP:0001404) | 1.98435069 |
152 | Stenosis of the external auditory canal (HP:0000402) | 1.98422516 |
153 | Chronic hepatic failure (HP:0100626) | 1.98414647 |
154 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98308093 |
155 | Abnormal protein glycosylation (HP:0012346) | 1.97439883 |
156 | Abnormal glycosylation (HP:0012345) | 1.97439883 |
157 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97439883 |
158 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97439883 |
159 | Cerebral edema (HP:0002181) | 1.96806527 |
160 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95834114 |
161 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95834114 |
162 | Increased cerebral lipofuscin (HP:0011813) | 1.93474470 |
163 | Abnormal platelet function (HP:0011869) | 1.92935672 |
164 | Increased CSF lactate (HP:0002490) | 1.92145573 |
165 | Proximal tubulopathy (HP:0000114) | 1.90956109 |
166 | Toxemia of pregnancy (HP:0100603) | 1.90049349 |
167 | Hypoplastic left heart (HP:0004383) | 1.89886786 |
168 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88173592 |
169 | Cavernous hemangioma (HP:0001048) | 1.87653904 |
170 | Anencephaly (HP:0002323) | 1.86381853 |
171 | Hepatic necrosis (HP:0002605) | 1.86275339 |
172 | Progressive macrocephaly (HP:0004481) | 1.85909290 |
173 | Supernumerary spleens (HP:0009799) | 1.85706435 |
174 | Chronic sinusitis (HP:0011109) | 1.85638524 |
175 | Cone-rod dystrophy (HP:0000548) | 1.85311836 |
176 | Pancreatitis (HP:0001733) | 1.84909146 |
177 | Ileus (HP:0002595) | 1.83822905 |
178 | Glycosuria (HP:0003076) | 1.83363057 |
179 | Abnormality of urine glucose concentration (HP:0011016) | 1.83363057 |
180 | Muscle fiber atrophy (HP:0100295) | 1.80650271 |
181 | Long clavicles (HP:0000890) | 1.80088905 |
182 | Symptomatic seizures (HP:0011145) | 1.80038404 |
183 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79834142 |
184 | Decreased subcutaneous fat (HP:0001002) | 1.75591083 |
185 | True hermaphroditism (HP:0010459) | 1.75259281 |
186 | Epidermoid cyst (HP:0200040) | 1.73610519 |
187 | Methylmalonic aciduria (HP:0012120) | 1.72900165 |
188 | Hemangiomatosis (HP:0007461) | 1.72839362 |
189 | Abnormality of midbrain morphology (HP:0002418) | 1.72547956 |
190 | Molar tooth sign on MRI (HP:0002419) | 1.72547956 |
191 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72520652 |
192 | Abnormality of glycolysis (HP:0004366) | 1.71048477 |
193 | Lethargy (HP:0001254) | 1.70808351 |
194 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.69665688 |
195 | Dicarboxylic aciduria (HP:0003215) | 1.69665688 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K3 | 4.58780875 |
2 | TXK | 3.74029069 |
3 | MAP4K1 | 3.54162109 |
4 | MAP3K14 | 3.32738994 |
5 | FGR | 2.92992189 |
6 | NME2 | 2.72233334 |
7 | TBK1 | 2.70630737 |
8 | CDK9 | 2.70603353 |
9 | JAK3 | 2.63515193 |
10 | EPHB2 | 2.62113618 |
11 | BLK | 2.61520450 |
12 | IRAK4 | 2.61195831 |
13 | VRK2 | 2.56484323 |
14 | KIT | 2.48067548 |
15 | IKBKE | 2.42126145 |
16 | PIM2 | 2.40252913 |
17 | BCKDK | 2.36923704 |
18 | TYK2 | 2.35131786 |
19 | TEC | 2.33812825 |
20 | NTRK2 | 2.22407193 |
21 | IKBKB | 2.18874266 |
22 | IRAK3 | 2.13652625 |
23 | MAP4K2 | 2.07831264 |
24 | BTK | 2.03627064 |
25 | ZAP70 | 2.01881068 |
26 | TGFBR2 | 1.83176804 |
27 | MAP3K12 | 1.82100468 |
28 | RIPK4 | 1.80676940 |
29 | SGK494 | 1.72241925 |
30 | SGK223 | 1.72241925 |
31 | SYK | 1.60606179 |
32 | MST4 | 1.54222957 |
33 | PBK | 1.52332834 |
34 | NLK | 1.36206633 |
35 | WNK3 | 1.31885240 |
36 | LCK | 1.31537390 |
37 | MAP3K13 | 1.30280347 |
38 | SGK2 | 1.29980190 |
39 | LYN | 1.28924622 |
40 | ITK | 1.26746130 |
41 | ADRBK1 | 1.26620860 |
42 | DYRK2 | 1.25625168 |
43 | JAK1 | 1.24937726 |
44 | PIM1 | 1.24844803 |
45 | SIK3 | 1.24305982 |
46 | TGFBR1 | 1.23554264 |
47 | TRIM28 | 1.23371686 |
48 | CHUK | 1.23342512 |
49 | MUSK | 1.18323097 |
50 | TESK2 | 1.17052083 |
51 | CSF1R | 1.16442345 |
52 | GRK1 | 1.10994289 |
53 | BMPR2 | 1.10513764 |
54 | NEK9 | 1.10160556 |
55 | RPS6KA4 | 1.04545970 |
56 | MAP2K3 | 1.04501977 |
57 | OBSCN | 1.04305142 |
58 | CSNK1A1 | 1.04000840 |
59 | HCK | 1.02710057 |
60 | TRPM7 | 1.01640458 |
61 | BUB1 | 1.01527729 |
62 | NEK1 | 1.01516126 |
63 | VRK1 | 1.00444738 |
64 | MATK | 0.97581566 |
65 | MAP3K11 | 0.96217588 |
66 | PAK4 | 0.94982290 |
67 | ERBB3 | 0.94513708 |
68 | KDR | 0.94482067 |
69 | MYLK | 0.94381786 |
70 | INSRR | 0.91994944 |
71 | TLK1 | 0.90540859 |
72 | CLK1 | 0.89222831 |
73 | YES1 | 0.88496922 |
74 | FGFR3 | 0.86716930 |
75 | LRRK2 | 0.86578146 |
76 | FGFR4 | 0.85127207 |
77 | STK16 | 0.84645793 |
78 | LMTK2 | 0.83853345 |
79 | CSK | 0.83747883 |
80 | AURKA | 0.82897264 |
81 | CSNK1G3 | 0.80921700 |
82 | EPHA3 | 0.80870814 |
83 | STK10 | 0.78038046 |
84 | TAOK3 | 0.76861241 |
85 | FLT3 | 0.76178346 |
86 | NTRK3 | 0.75690996 |
87 | PINK1 | 0.72903525 |
88 | GRK7 | 0.72713522 |
89 | ADRBK2 | 0.68340899 |
90 | PRKCE | 0.67866330 |
91 | NUAK1 | 0.67458028 |
92 | TNIK | 0.67135894 |
93 | STK4 | 0.66678646 |
94 | MAP2K6 | 0.65543998 |
95 | SGK3 | 0.65345420 |
96 | IRAK1 | 0.65181021 |
97 | JAK2 | 0.64483260 |
98 | EIF2AK2 | 0.64463167 |
99 | PHKG2 | 0.63567155 |
100 | PHKG1 | 0.63567155 |
101 | PRKG2 | 0.62840625 |
102 | TAF1 | 0.62491814 |
103 | SRPK1 | 0.62450998 |
104 | CCNB1 | 0.61691602 |
105 | CSNK1G2 | 0.61473814 |
106 | PRKCI | 0.61008958 |
107 | LIMK1 | 0.60410742 |
108 | UHMK1 | 0.59190944 |
109 | RPS6KA5 | 0.58936178 |
110 | CSNK1G1 | 0.58435907 |
111 | CAMK2D | 0.58265946 |
112 | MAP2K7 | 0.57502618 |
113 | RPS6KB2 | 0.56835970 |
114 | PIK3CG | 0.56491309 |
115 | MARK3 | 0.56036573 |
116 | ACVR1B | 0.55749349 |
117 | NEK6 | 0.55679319 |
118 | TIE1 | 0.54375504 |
119 | ERN1 | 0.54360342 |
120 | RPS6KA6 | 0.54071939 |
121 | EIF2AK1 | 0.53973755 |
122 | FES | 0.52688970 |
123 | MAPKAPK2 | 0.52267844 |
124 | PRKCQ | 0.51152804 |
125 | EIF2AK3 | 0.51052683 |
126 | PIK3CA | 0.50421228 |
127 | PDK2 | 0.49614015 |
128 | MAP2K1 | 0.49587420 |
129 | INSR | 0.49535434 |
130 | TNK2 | 0.49260756 |
131 | ILK | 0.48311107 |
132 | EPHB1 | 0.47384698 |
133 | CSNK1A1L | 0.47269979 |
134 | PLK4 | 0.46869043 |
135 | MAP3K4 | 0.46568039 |
136 | CSNK2A1 | 0.46555110 |
137 | BMPR1B | 0.45628135 |
138 | PRKCD | 0.45416141 |
139 | GRK6 | 0.43752904 |
140 | STK24 | 0.43633866 |
141 | FRK | 0.43198313 |
142 | CAMK2G | 0.43131041 |
143 | PLK3 | 0.42857897 |
144 | BCR | 0.42857571 |
145 | MAPKAPK5 | 0.42747409 |
146 | ZAK | 0.42643220 |
147 | DYRK3 | 0.41857093 |
148 | PRKCA | 0.39493673 |
149 | DAPK3 | 0.38883167 |
150 | EGFR | 0.38267030 |
151 | ABL1 | 0.38083874 |
152 | CAMK2A | 0.36960490 |
153 | MAPK4 | 0.36651531 |
154 | RPS6KC1 | 0.36364033 |
155 | RPS6KL1 | 0.36364033 |
156 | MKNK1 | 0.35983369 |
157 | PRKACA | 0.35636304 |
158 | RPS6KB1 | 0.34757961 |
159 | CAMK2B | 0.34353070 |
160 | ARAF | 0.32908389 |
161 | ABL2 | 0.32388121 |
162 | DYRK1B | 0.30180818 |
163 | ATR | 0.29635823 |
Rank | Gene Set | Z-score |
---|---|---|
1 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.75988516 |
2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.49516639 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.23563078 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.94365529 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94126009 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.86250203 |
7 | Ribosome_Homo sapiens_hsa03010 | 2.85554130 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.72547018 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66168624 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61058640 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52794907 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52297062 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45677441 |
14 | Sulfur relay system_Homo sapiens_hsa04122 | 2.25407108 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22979214 |
16 | Measles_Homo sapiens_hsa05162 | 2.19911050 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17475799 |
18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.14880592 |
19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06398130 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06378836 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05273725 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04922615 |
23 | Asthma_Homo sapiens_hsa05310 | 1.98831169 |
24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.98334948 |
25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96543571 |
26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84590049 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75966008 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75577098 |
29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74756530 |
30 | Legionellosis_Homo sapiens_hsa05134 | 1.71993655 |
31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67373135 |
32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61170814 |
33 | Pertussis_Homo sapiens_hsa05133 | 1.59455084 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57571205 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56174271 |
36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55836464 |
37 | Proteasome_Homo sapiens_hsa03050 | 1.55038723 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52088487 |
39 | Malaria_Homo sapiens_hsa05144 | 1.50519006 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49045795 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.45551744 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43465034 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36607132 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 1.35888864 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34515052 |
46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.34443000 |
47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33028615 |
48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32887153 |
49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32128913 |
50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31092058 |
51 | Shigellosis_Homo sapiens_hsa05131 | 1.30791790 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30380459 |
53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29418079 |
54 | Peroxisome_Homo sapiens_hsa04146 | 1.28522194 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27163820 |
56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26668705 |
57 | DNA replication_Homo sapiens_hsa03030 | 1.26508600 |
58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26383629 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26229643 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24695258 |
61 | Protein export_Homo sapiens_hsa03060 | 1.24205481 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 1.22212822 |
63 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21904568 |
64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18137170 |
65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17652670 |
66 | Apoptosis_Homo sapiens_hsa04210 | 1.16469697 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15445266 |
68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14485823 |
69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13395386 |
70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12797177 |
71 | Morphine addiction_Homo sapiens_hsa05032 | 1.11777698 |
72 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10891318 |
73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09664941 |
74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06931982 |
75 | Hepatitis B_Homo sapiens_hsa05161 | 1.06768075 |
76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03132755 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01407042 |
78 | Base excision repair_Homo sapiens_hsa03410 | 1.01096334 |
79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97600224 |
80 | Platelet activation_Homo sapiens_hsa04611 | 0.94749822 |
81 | Mismatch repair_Homo sapiens_hsa03430 | 0.94470632 |
82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94277820 |
83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94121254 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92714908 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92249677 |
86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91965890 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.91390774 |
88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91147298 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89407009 |
90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87717544 |
91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86205530 |
92 | Homologous recombination_Homo sapiens_hsa03440 | 0.85921996 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85831585 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85281007 |
95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83819947 |
96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80972142 |
97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80256814 |
98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79800996 |
99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79698111 |
100 | RNA polymerase_Homo sapiens_hsa03020 | 0.78678521 |
101 | Hepatitis C_Homo sapiens_hsa05160 | 0.78309209 |
102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.77456843 |
103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76214024 |
104 | Phagosome_Homo sapiens_hsa04145 | 0.75977899 |
105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74543477 |
106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74497932 |
107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73894746 |
108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71062339 |
109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70160548 |
110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69812397 |
111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69594270 |
112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68126310 |
113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67917340 |
114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67861092 |
115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67090391 |
116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66992765 |
117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65975217 |
118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64922026 |
119 | Spliceosome_Homo sapiens_hsa03040 | 0.64644149 |
120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63290255 |
121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62186717 |
122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60869681 |
123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57934882 |
124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57750669 |
125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54691428 |
126 | Purine metabolism_Homo sapiens_hsa00230 | 0.54198480 |
127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54009980 |
128 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53183600 |
129 | RNA degradation_Homo sapiens_hsa03018 | 0.51910208 |
130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50919941 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50044036 |
132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49286453 |
133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48143030 |
134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47591557 |
135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47048961 |
136 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46470004 |
137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45995820 |
138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45444790 |
139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44979529 |
140 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44494867 |
141 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44002692 |
142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43674313 |
143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42871593 |
144 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42634198 |
145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39636882 |
146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39622258 |
147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39398703 |
148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39315718 |
149 | RNA transport_Homo sapiens_hsa03013 | 0.37837852 |
150 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37066688 |
151 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36868935 |
152 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35206642 |
153 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34487069 |
154 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33425601 |
155 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32157331 |
156 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.31329733 |
157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30750535 |
158 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25363671 |
159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24332658 |
160 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22694924 |
161 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22680539 |